Chikicha Editorial & Medical Disclaimer
This article is intended for education and public awareness and is based on scientific literature, peer-reviewed research, and recognized international authorities. The author is not a licensed medical doctor, psychiatrist, or healthcare professional, and this article does not constitute medical advice, diagnosis, or treatment. Readers should consult qualified healthcare professionals regarding individual health concerns or decisions.
The author and Chikicha do not sell, endorse, or promote products, supplements, treatments, or medical interventions discussed in relation to this topic.
The Biology Behind the Decline
In Article 1, we established that sarcopenia is more than the loss of muscle mass. Contemporary consensus recognizes muscle mass, muscle strength, and muscle-specific strength as components of sarcopenia, while impaired physical performance is an important outcome (Kirk et al., 2024).
The next question is more fundamental: Why does the aging muscle change in the first place?
Sarcopenia develops through the interaction of multiple biological processes involving muscle protein turnover, muscle fibers, the nervous system, cellular energy production, regeneration, inflammation, hormones, metabolism, and the tissue environment surrounding the muscle. Researchers increasingly describe these processes as interconnected rather than independent causes (Granic & Suetterlin, 2023; Grima-Terrén et al., 2024).
To understand sarcopenia, therefore, we have to move inside the muscle.
The Muscle Is Never Static
Skeletal muscle may appear stable, but biologically it is continually being renewed.
Muscle proteins are constantly being synthesized, broken down, repaired, and remodeled. Muscle mass at any given time reflects the balance between these processes and the stimuli that regulate them.
McKendry et al. (2021) reviewed the effects of aging, resistance exercise, and disuse on muscle protein metabolism. Their review emphasized that skeletal muscle mass is regulated through the dynamic relationship between muscle protein synthesis and muscle protein breakdown. They also examined how aging and periods of disuse alter this balance and contribute to anabolic resistance.
This provides a useful starting point for understanding sarcopenia: the aging muscle is not simply losing tissue with time; its ability to maintain and rebuild that tissue is changing. This raises a more precise question: does older muscle respond as effectively to the signals that normally stimulate protein synthesis, growth, and repair?
That brings us to one of the most studied concepts in the biology of sarcopenia: anabolic resistance.
When Muscle Does Not Respond the Same Way
Anabolic resistance describes a reduced or altered muscle-building response to stimuli that would normally promote muscle protein synthesis, particularly dietary protein and physical activity.
Aragon et al. (2023) reviewed the evidence surrounding age-related anabolic resistance and identified several mechanisms that may contribute, including altered anabolic signaling, changes in amino-acid delivery and utilization, physical inactivity, and systemic inflammation. But the evidence does not support the idea that older muscle simply stops responding. That distinction became particularly important in a 2026 systematic review and meta-analysis by Kristiansen et al.
The researchers examined 46 studies involving 1,280 participants to determine how aging affects muscle protein synthesis under different conditions, including fasting, feeding, and exercise. Their analysis found modest reductions in muscle protein synthesis among older adults under post-absorptive and post-meal conditions.
However, the response to exercise was not uniformly diminished. Several studies found no significant age-related difference in post-exercise muscle protein synthesis, and the authors concluded that although aging is associated with anabolic resistance, the anabolic response to exercise can remain preserved (Kristiansen et al., 2026).
That finding is important because it changes the way we should understand anabolic resistance, as it is not a biological declaration that the aging muscle can no longer adapt. Rather, aging may change how strongly and under what conditions the muscle responds to anabolic stimuli. The muscle remains biologically responsive, but its responsiveness, however, is no longer identical to that of younger muscle.
The Muscle Fiber Changes
Muscle is not a uniform tissue, skeletal muscle contains different fiber types with different contractile characteristics, and aging does not affect all fibers in exactly the same way.
Grima-Terrén et al. (2024), in their review of muscle aging and sarcopenia, described age-related changes in muscle-fiber composition, fiber size, contractile properties, extracellular matrix, mitochondrial function, inflammation, and neurological input.
Damanti et al. (2025) similarly described changes affecting muscle fibers, myonuclei, protein regulation, regeneration, and neural input. Their review highlighted the particular vulnerability of fast-twitch fibers to age-related denervation and atrophy. This matters because the loss or alteration of muscle fibers affects more than muscle size. Different fibers contribute differently to force production, rapid movement, and functional capacity.
This provides another explanation for a finding established in Article 1: Muscle strength and power can decline at a different rate from muscle mass, shifting the fundamental question from how much muscle remains to what kind of muscle remains, how well its fibers function, and how effectively they can be activated.
Muscle Cannot Function Without the Nervous System
A muscle does not generate movement independently.
Every voluntary contraction depends on communication between the nervous system and muscle. The basic functional unit of this system is the motor unit, consisting of a motor neuron and the muscle fibers it controls. The neuromuscular junction is the specialized connection through which the nerve communicates with the muscle fiber. As muscle ages, this neurological connection also changes.
Arnold and Clark (2023) reviewed the evidence concerning neuromuscular-junction transmission failure in aging and sarcopenia. They identified the neuromuscular junction as a critical interface between the neurological and muscular systems and examined whether age-related deterioration at this interface could contribute to declining muscle function.
Their review found substantial evidence of age-related neuromuscular-junction changes in animal models. However, they also emphasized an important limitation: direct evidence in older humans, particularly people with sarcopenia, remains limited and sometimes contradictory.
Their conclusion was therefore cautious. Neuromuscular-junction dysfunction is a plausible contributor to sarcopenia, but its precise contribution to human sarcopenia remains insufficiently established (Arnold & Clark, 2023).
That caution is important, as the biological explanation for sarcopenia should not turn every plausible mechanism into a proven cause. But subsequent evidence has continued to strengthen interest in the neuromuscular system.
Image
A 2025 systematic review examining motor units and neuromuscular-junction dysfunction during aging and sarcopenia identified evidence of neuromuscular transmission instability, motor-unit loss, compensatory remodeling, and impaired neuromuscular activation. The review suggested that some neuromuscular changes may occur before obvious muscle atrophy and weakness.
The emerging picture is therefore one in which aging affects not only the muscle tissue itself but also the neurological system responsible for recruiting and coordinating that tissue. This helps explain why the capacity of muscle to produce force can change substantially even when measurable muscle mass has not declined to the same extent.
The Muscle Needs Energy
Every muscle contraction requires energy.
Mitochondria are central to cellular energy production, and skeletal muscle contains a large mitochondrial network because of its continuous demand for energy. For this reason, researchers have investigated mitochondrial dysfunction as one of the biological features associated with muscle aging and sarcopenia.
Granic and Suetterlin (2023) identified mitochondrial dysfunction among the hallmarks of aging relevant to skeletal muscle. Grima-Terrén et al. (2024) similarly identified mitochondrial alterations as part of the complex biological changes accompanying muscle aging.
Marzetti et al. (2024) examined mitochondrial pathways within the broader context of sarcopenia and geroscience. Their review reported associations between impaired mitochondrial bioenergetics and measures such as aerobic capacity, muscle strength, and physical performance. They also examined mitochondrial quality-control mechanisms, including autophagy and mitophagy, which help maintain the quality of the mitochondrial population.
But here again, the evidence requires nuance.
Mitochondrial dysfunction may contribute to muscle deterioration, but researchers continue to debate the direction and significance of the relationship. Some mitochondrial changes may also reflect adaptation to reduced physical activity and energy demand in already weakened muscle.
The appropriate conclusion is therefore not that mitochondrial dysfunction is the cause of sarcopenia. Rather, mitochondrial health appears to be one component of the biological environment that influences the aging muscle's ability to produce energy, respond to stress, and maintain function.
The Muscle Must Repair Itself
Skeletal muscle has an intrinsic capacity for repair. One of the key players is the satellite cell, a muscle stem cell located alongside muscle fibers. When muscle is damaged or requires remodeling, satellite cells can become activated and contribute to regeneration. But the regenerative environment changes with age.
Damanti et al. (2025) reviewed the molecular constraints affecting aging muscle and described age-related changes involving satellite cells, myonuclei, protein regulation, inflammation, metabolism, neural input, and tissue regeneration.
Their synthesis suggests that the aging muscle faces multiple constraints at the same time. The problem is not simply that there are fewer muscle cells. The cells and systems responsible for maintaining and repairing the tissue are also changing.
Aging muscle faces a dual challenge of heightened vulnerability and a diminished regenerative capacity, yet repair does not vanish entirely; rather, the underlying biological environment simply grows less favorable for efficient healing.
The Environment Around the Muscle Changes
Muscle is surrounded by blood vessels, connective tissue, immune cells, fibroblasts, satellite cells, and other components that influence how muscle functions and repairs itself.
Granic and Suetterlin (2023) examined skeletal muscle aging through the broader framework of the biological hallmarks of aging. Their review connected sarcopenia with processes including mitochondrial dysfunction, altered nutrient sensing, cellular communication, cellular senescence, vascular changes, and other age-related alterations.
This perspective is important because it moves the explanation beyond the muscle fiber itself. Skeletal muscle does not function in isolation; it exists within a continuously changing biological environment. As the body ages, changes in the surrounding tissue, circulation, immune system, metabolism, and cellular communication can alter the conditions in which muscle must maintain, repair, and adapt itself.
These interactions help explain why sarcopenia cannot be understood solely as a problem of what happens within the muscle fiber. The muscle is shaped, supported, and challenged by the biological environment around it. As that environment changes with age, its capacity to sustain muscle integrity and function may also change.
Sarcopenia, therefore, is not simply a problem inside the muscle. It is also a problem of the biological environment in which the muscle must survive, adapt, and function.
Image
Inflammation Alters the Landscape
Aging is accompanied in many people by persistent, low-grade inflammatory activity, often described as inflammaging. Inflammation itself is not harmful. It is an essential part of the body's response to injury and infection. The concern is what happens when inflammatory signaling becomes chronically elevated or dysregulated.
Recent reviews have identified inflammation as one of the interconnected biological processes associated with sarcopenia. Rather than functioning as a single cause, inflammatory signaling can interact with protein metabolism, mitochondrial function, insulin signaling, tissue regeneration, adipose tissue, and immune aging.
A 2025 review of inflammation and sarcopenia highlighted these interactions, linking chronic low-grade inflammation with immunosenescence, obesity, lipid infiltration, gut-related changes, and alterations in satellite-cell function. Taken together, these findings show how inflammatory processes can interact with multiple pathways involved in muscle maintenance and repair.
This supports an important principle: inflammation is part of the biological network surrounding muscle aging, not a single switch that turns sarcopenia on. This distinction matters because it keeps the interpretation proportional to what current research can actually demonstrate.
Hormonal Aging Adds Another Layer
Muscle is also an endocrine-responsive tissue, hormones influence muscle protein metabolism, growth, maintenance, glucose regulation, and other processes involved in muscular health. As people age, the hormonal environment changes.
Hosoi et al. (2024) reviewed the role of sex hormones in age-related sarcopenia and frailty, describing the anabolic effects of androgens on skeletal muscle and the contribution of estrogen to muscle maintenance. Their review also emphasized that the biological pathways connecting age-related hormonal changes to sarcopenia remain incompletely understood, and that evidence supporting hormone replacement as a treatment for sarcopenia has been inconsistent. These findings suggest that endocrine changes may influence the aging muscle, but their effects cannot be separated easily from the other biological processes occurring at the same time.
Hormonal change is therefore one component of the biological landscape rather than a complete explanation for sarcopenia.
Aging muscle adapts to a changing endocrine environment while simultaneously responding to alterations in the nervous system, metabolism, cellular repair, nutrition, inflammation, and physical activity. Sarcopenia emerges from the interaction of these processes, making its trajectory more complex than any single hormonal change can explain.
Muscle, Metabolism, and What Happens Within the Tissue
Skeletal muscle is not only responsible for movement; it is also one of the body’s major metabolic tissues, contributing substantially to glucose disposal, energy use, and metabolic regulation. This creates a bidirectional relationship between muscle and metabolic health. Alterations in insulin signaling and metabolic function can affect the maintenance and function of skeletal muscle, while declines in muscle quantity and quality can reduce its metabolic capacity. As the muscle ages, therefore, its metabolic environment becomes part of the process through which its structure and function change.
One of the clearest examples of this relationship is myosteatosis, the excessive accumulation of fat within and around skeletal muscle. Myosteatosis is not simply a reflection of overall body fat; the location and characteristics of fat within the muscle can alter the tissue itself. Dondero et al. (2024) reviewed evidence in older adults linking myosteatosis with increased passive stiffness, insulin resistance, altered muscle mechanics, inflammatory activity, and reduced force production.
These changes help explain how muscle quality can deteriorate even when a substantial reduction in muscle quantity is not yet apparent. A 2021 systematic review and meta-analysis likewise examined myosteatosis as a phenomenon distinct from sarcopenia, while identifying its associations with aging, metabolic dysfunction, inflammation, and adverse clinical outcomes. The authors also noted considerable heterogeneity in how myosteatosis is defined and measured.
Taken together, these findings sharpen an important distinction in the biology of muscle aging. Muscle quantity and muscle quality are related, but they are not interchangeable. What matters is not only how much muscle remains, but also the metabolic and structural environment within and around that muscle and how these changes affect what the muscle is ultimately capable of doing.
These Mechanisms Do Not Operate Alone
By this point, the biological picture is considerably more complex than a simple sequence of muscle loss. Aging changes several systems that collectively maintain muscle, and these changes can reinforce one another.
Muscle protein turnover becomes less responsive, anabolic resistance can weaken the response to nutritional and exercise stimuli, and muscle fibers can atrophy or change in composition. At the same time, motor units and neuromuscular connections may become less effective, mitochondrial function and cellular quality control can deteriorate, and satellite-cell activity and regenerative capacity may decline. Changes in inflammation, hormones, metabolism, and fat accumulation within muscle add further pressures to an already changing tissue environment.
These processes do not occur independently. Damanti et al. (2025) described sarcopenia as the convergence of molecular, cellular, hormonal, nutritional, and neurological alterations that impair muscle maintenance and regeneration. Grima-Terrén et al. (2024) similarly emphasized that muscle aging results from interactions among multiple biological pathways rather than from a single pathological mechanism.
The significance of these findings lies in their interconnectedness: a change in one system can alter the conditions in which another system must function.
Sarcopenia Is a Systems Problem
The muscle is therefore not declining because one biological switch has been turned off. Sarcopenia emerges as multiple systems that once worked together to maintain muscle gradually become less effective and increasingly influence one another. Understanding this interconnected biology is essential because it also explains why the pace of muscle decline can differ substantially between individuals.
But the Aging Muscle Is Not Biologically Inert
There is an important counterpoint to the biological changes described above: the aging muscle retains the capacity to respond and adapt. Kristiansen et al. (2026) found that although older adults show age-related reductions in muscle protein synthesis under post-absorptive and feeding conditions, the anabolic response to exercise was not uniformly diminished. Their findings are important because they challenge the idea that aging inevitably eliminates the muscle’s ability to respond to an appropriate stimulus.
The older muscle may begin from a different biological baseline, require stronger or more appropriate stimuli, and have less physiological reserve than younger muscle, but it remains biologically responsive. This distinction is central to understanding sarcopenia without reducing aging to an inevitable process of muscular failure. Aging changes the conditions under which muscle must maintain itself; it does not necessarily remove the capacity for adaptation. The more useful scientific question, therefor- how those changes interact with the conditions in which a person lives.
Image
From Biological Vulnerability to Functional Decline
We can now see the trajectory more clearly. Changes in protein turnover and anabolic signaling can reduce the efficiency of muscle maintenance, while alterations in muscle fibers, motor-unit function, mitochondrial capacity, and regenerative mechanisms can further weaken the tissue’s ability to adapt. At the same time, inflammation, metabolic dysfunction, hormonal changes, and fat accumulation can alter the environment in which muscle must function. These mechanisms are interconnected, and their combined effects can progressively reduce strength, power, and functional reserve.
This is where the biology of sarcopenia meets the lived experience of aging. Reduced muscular reserve can influence whether a person recovers quickly from illness or struggles to regain function, climbs stairs confidently or begins avoiding them, or recovers from a stumble or sustains a serious fall. The significance of the biology therefore lies not simply in what happens to the muscle as tissue, but in what happens to the person when muscular capacity can no longer meet the demands of everyday life. Muscle biology ultimately matters because physical function is one of the ways that biological capacity becomes lived experience.
What We Know, and What We Still Do Not Know
The science has moved considerably beyond the idea that sarcopenia is simply age-related muscle loss. Evidence now points to interacting changes in protein metabolism, anabolic responsiveness, muscle fibers, motor units, mitochondria, regenerative mechanisms, inflammation, hormonal signaling, metabolism, and tissue composition. Together, these findings support an understanding of sarcopenia as a multidimensional biological process rather than the consequence of a single failing mechanism.
At the same time, the evidence requires careful interpretation. These mechanisms do not have equal evidence behind them, and not every association establishes causation. Some are supported by substantial human evidence, while others rely more heavily on mechanistic research or animal models, and several remain actively debated. This is not a weakness of the field; it reflects the current state of scientific knowledge and the complexity of studying a process in which multiple biological systems change simultaneously.
What the evidence increasingly supports is that sarcopenia develops through the gradual interaction of systems responsible for maintaining muscle quantity, quality, strength, and adaptability. Biological vulnerability, however, does not determine the pace of decline by itself. The conditions in which muscle ages also matter: periods of inactivity, acute illness, hospitalization, inadequate nutrition, metabolic dysfunction, chronic disease, and other physiological stresses can place additional demands on an already changing muscular system. These exposures can shift the trajectory from gradual biological change toward more rapid loss of strength and function.
And this brings us to the next question in the story, what makes it happen faster?
Arcticle 3 - The Muscle Longevity: What Makes Sarcopenia Happen Faster?
Image
Suggested Citation
Lendez, M.L. (2026). The Muscle of Longevity: Why Does Sarcopenia Happen? Chikicha.com (the author is the developer of the Ikigai-Bayanihan Framework for Purposeful Aging).
About the Author
Dr. Mariza Lendez is a researcher, social entrepreneur, and creator of the Ikigai-Bayanihan (Purpose + Collective Ethos) Retirement Model, an innovative framework that integrates purpose, community engagement, and sustainability to support meaningful aging and later-life well-being
References
Arnold, W. D., & Clark, B. C. (2023). Neuromuscular junction transmission failure in aging and sarcopenia: The nexus of the neurological and muscular systems. Ageing Research Reviews, 89, 101966. https://doi.org/10.1016/j.arr.2023.101966
Aragon, A. A., Tipton, K. D., & Schoenfeld, B. J. (2023). Age-related muscle anabolic resistance: Inevitable or preventable? Nutrition Reviews, 81(4), 441–454. https://doi.org/10.1093/nutrit/nuac062
Damanti, S., Senini, E., De Lorenzo, R., Merolla, A., Santoro, S., Festorazzi, C., Messina, M., Vitali, G., Sciorati, C., Manfredi, A. A., & Rovere-Querini, P. (2025). Molecular constraints of sarcopenia in the ageing muscle. Frontiers in Aging, 6, 1588014. https://doi.org/10.3389/fragi.2025.1588014
Dondero, K., Friedman, B., Rekant, J., Landers-Ramos, R., & Addison, O. (2024). The effects of myosteatosis on skeletal muscle function in older adults. Physiological Reports, 12(9), e16042. https://doi.org/10.14814/phy2.16042
Granic, A., & Suetterlin, K. (2023). Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men. Clinical Science, 137(22), 1721–1751. https://doi.org/10.1042/CS20230319
Grima-Terrén, M., Campanario, S., Ramírez-Pardo, I., Cisneros, A., Hong, X., Perdiguero, E., Serrano, A. L., Isern, J., & Muñoz-Cánoves, P. (2024). Muscle aging and sarcopenia: The pathology, etiology, and most promising therapeutic targets. Molecular Aspects of Medicine, 100, 101319. https://doi.org/10.1016/j.mam.2024.101319
Hosoi, T., Yakabe, M., Hashimoto, S., Akishita, M., & Ogawa, S. (2024). The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reproductive Medicine and Biology, 23(1), e12569. https://doi.org/10.1002/rmb2.12569
Kristiansen, J. B., Vissing, K., & Nielsen, J. L. (2026). Age-related anabolic resistance and post-absorptive muscle protein synthesis: Integrative evidence from a systematic review and meta-analysis. Frontiers in Physiology, 17, 1740284. https://doi.org/10.3389/fphys.2026.1740284
Marzetti, E., Calvani, R., Coelho-Junior, H. J., & Picca, A. (2024). Mitochondrial pathways and sarcopenia in the geroscience era. The Journal of Nutrition, Health & Aging, 28(12), 100397. https://doi.org/10.1016/j.jnha.2024.100397
McKendry, J., Stokes, T., Mcleod, J. C., & Phillips, S. M. (2021). Resistance exercise, aging, disuse, and muscle protein metabolism. Comprehensive Physiology, 11(3), 2249–2278. https://doi.org/10.1002/cphy.c200029